![Tumor Marker:- Part 4 – CA-Antigens, CA 15-3, CA 549, CA 27.29, CA 125, CA 19-9, CA 72-4 – Labpedia.net Tumor Marker:- Part 4 – CA-Antigens, CA 15-3, CA 549, CA 27.29, CA 125, CA 19-9, CA 72-4 – Labpedia.net](https://labpedia.net/wp-content/uploads/2020/01/Tumor-marker-diagnosis-prognosis-3-1024x807.jpg)
Tumor Marker:- Part 4 – CA-Antigens, CA 15-3, CA 549, CA 27.29, CA 125, CA 19-9, CA 72-4 – Labpedia.net
![Preoperative CA 15-3 and CEA serum levels as predictor for breast cancer outcomes - Annals of Oncology Preoperative CA 15-3 and CEA serum levels as predictor for breast cancer outcomes - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/70b014bf-11a1-40bd-a86b-7410020eec4a/gr1.jpg)
Preoperative CA 15-3 and CEA serum levels as predictor for breast cancer outcomes - Annals of Oncology
![Electrochemical immunosensor for the breast cancer marker CA 15–3 based on the catalytic activity of a CuS/reduced graphene oxide nanocomposite towards the electrooxidation of catechol | SpringerLink Electrochemical immunosensor for the breast cancer marker CA 15–3 based on the catalytic activity of a CuS/reduced graphene oxide nanocomposite towards the electrooxidation of catechol | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00604-017-2532-5/MediaObjects/604_2017_2532_Figa_HTML.gif)
Electrochemical immunosensor for the breast cancer marker CA 15–3 based on the catalytic activity of a CuS/reduced graphene oxide nanocomposite towards the electrooxidation of catechol | SpringerLink
![A FRET immunosensor for sensitive detection of CA 15-3 tumor marker in human serum sample and breast cancer cells using antibody functionalized luminescent carbon-dots and AuNPs-dendrimer aptamer as donor-acceptor pair - ScienceDirect A FRET immunosensor for sensitive detection of CA 15-3 tumor marker in human serum sample and breast cancer cells using antibody functionalized luminescent carbon-dots and AuNPs-dendrimer aptamer as donor-acceptor pair - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0003269718304263-fx1.jpg)
A FRET immunosensor for sensitive detection of CA 15-3 tumor marker in human serum sample and breast cancer cells using antibody functionalized luminescent carbon-dots and AuNPs-dendrimer aptamer as donor-acceptor pair - ScienceDirect
![CLO20-029: The Prognostic and Predictive Significance of Joint İnvestigation of Tumor Marker CA 15-3 and Vitamin D in Breast Cancer Patients in: Journal of the National Comprehensive Cancer Network Volume 18 Issue 3.5 (2020) CLO20-029: The Prognostic and Predictive Significance of Joint İnvestigation of Tumor Marker CA 15-3 and Vitamin D in Breast Cancer Patients in: Journal of the National Comprehensive Cancer Network Volume 18 Issue 3.5 (2020)](https://jnccn.org/view/journals/jnccn/18/3.5/full-jnccn20197391t1.jpg)
CLO20-029: The Prognostic and Predictive Significance of Joint İnvestigation of Tumor Marker CA 15-3 and Vitamin D in Breast Cancer Patients in: Journal of the National Comprehensive Cancer Network Volume 18 Issue 3.5 (2020)
![The Use of Carbohydrate Antigen (CA) 15-3 as a Tumor Marker in Detecting Breast Cancer - SciAlert Responsive Version The Use of Carbohydrate Antigen (CA) 15-3 as a Tumor Marker in Detecting Breast Cancer - SciAlert Responsive Version](https://docsdrive.com/images/ansinet/pjbs/2008/tab2-2k8-5132.gif)
The Use of Carbohydrate Antigen (CA) 15-3 as a Tumor Marker in Detecting Breast Cancer - SciAlert Responsive Version
![Survival curves for patients with CA 15-3 >30 kU/l and no metastasis at... | Download Scientific Diagram Survival curves for patients with CA 15-3 >30 kU/l and no metastasis at... | Download Scientific Diagram](https://www.researchgate.net/profile/Jean-Pierre-Basuyau/publication/24213426/figure/fig1/AS:460229222637571@1486738605171/Survival-curves-for-patients-with-CA-15-3-30-kU-l-and-no-metastasis-at-diagnosis-M2-as.png)
Survival curves for patients with CA 15-3 >30 kU/l and no metastasis at... | Download Scientific Diagram
![Table 1 from Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers | Semantic Scholar Table 1 from Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bf27a8f33dc1177ab0c7cf3c2adec21f5727b20d/3-Table1-1.png)